Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

被引：1

作者：

Bhatt, Ankeet S. ^{[1
,2
,3
]}

Vaduganathan, Muthiah ^{[4
]}

Jena, Barada Prasad ^{[5
]}

Suminska, Sylwia ^{[6
]}

Eid, Carlos ^{[7
]}

Khairnar, Rahul ^{[8
]}

Farries, Gabriella ^{[6
]}

Senni, Michele ^{[9
]}

机构：

[1] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA

[2] Div Res, San Francisco, CA USA

[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA USA

[4] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA

[5] Novartis Global Serv Ctr, Hyderabad, India

[6] Novartis Corp Ctr, Dublin, Ireland

[7] Novartis Pharm Serv AG, Off Middle East & North Afr, Nairobi, Kenya

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Univ Milano Bicocca, Osped Papa Giovanni XXIII, Bergamo, Italy

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷 / 05期

关键词：

D O I：

10.1002/ejhf.3233

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1172 / 1174

页数：3

共 11 条

[1] Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management [J].

Bhatt, Ankeet S. ;

Vaduganathan, Muthiah ;

Claggett, Brian L. ;

Fonarow, Gregg C. ;

Packer, Milton ;

Pfeffer, Marc A. ;

Shah, Sanjiv J. ;

Shen, Xian ;

Cristino, Joaquim ;

Mcmurray, John J. V. ;

Solomon, Scott D. ;

Gaziano, Thomas A. .

JAMA CARDIOLOGY, 2023, 8 (11) :1041-1048

[2] Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States [J].

Greene, Stephen J. ;

Triana, Taylor S. ;

Ionescu-Ittu, Raluca ;

Shi, Sherry ;

Guerin, Annie ;

DeSouza, Mary M. ;

Kessler, Paul D. ;

Tugcu, Aylin ;

Borentain, Maria ;

Felker, G. Michael .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (07) :1023-1025

[3]

[Anonymous], 2022, Circulation, V145, pe1033, DOI [10.1161/CIR.0000000000001063, 10.1161/CIR.0000000000001073]

[4]

McDonagh TA., 2023, EUR J HEART

[5] Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry [J].

Savarese, G. ;

Hage, C. ;

Benson, L. ;

Schrage, B. ;

Thorvaldsen, T. ;

Lundberg, A. ;

Fudim, M. ;

Linde, C. ;

Dahlstrom, U. ;

Rosano, G. M. C. ;

Lund, L. H. .

JOURNAL OF INTERNAL MEDICINE, 2021, 289 (03) :369-384

[6] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction [J].

Solomon, S. D. ;

McMurray, J. J. V. ;

Anand, I. S. ;

Ge, J. ;

Lam, C. S. P. ;

Maggioni, A. P. ;

Martinez, F. ;

Packer, M. ;

Pfeffer, M. A. ;

Pieske, B. ;

Redfield, M. M. ;

Rouleau, J. L. ;

van Veldhuisen, D. J. ;

Zannad, F. ;

Zile, M. R. ;

Desai, A. S. ;

Claggett, B. ;

Jhund, P. S. ;

Boytsov, S. A. ;

Comin-Colet, J. ;

Cleland, J. ;

Dungen, H. -D. ;

Goncalvesova, E. ;

Katova, T. ;

Kerr Saraiva, J. F. ;

Lelonek, M. ;

Merkely, B. ;

Senni, M. ;

Shah, S. J. ;

Zhou, J. ;

Rizkala, A. R. ;

Gong, J. ;

Shi, V. C. ;

Lefkowitz, M. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17) :1609-1620

[7] Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure [J].

Solomon, Scott D. ;

Vaduganathan, Muthiah ;

Claggett, Brian L. ;

Packer, Milton ;

Zile, Michael ;

Swedberg, Karl ;

Rouleau, Jean ;

Pfeffer, Marc A. ;

Desai, Akshay ;

Lund, Lars H. ;

Kober, Lars ;

Anand, Inder ;

Sweitzer, Nancy ;

Linssen, Gerard ;

Merkely, Bela ;

Arango, Juan Luis ;

Vinereanu, Dragos ;

Chen, Chen-Huan ;

Senni, Michele ;

Sibulo, Antonio ;

Boytsov, Sergey ;

Shi, Victor ;

Rizkala, Adel ;

Lefkowitz, Martin ;

McMurray, John J., V .

CIRCULATION, 2020, 141 (05) :352-361

[8] Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction [J].

Stolfo, Davide ;

Lund, Lars H. ;

Sinagra, Gianfranco ;

Lindberg, Felix ;

Dahlstrom, Ulf ;

Rosano, Giuseppe ;

Savarese, Gianluigi .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (06) :526-535

[9] Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF [J].

Vaduganathan, Muthiah ;

Mentz, Robert J. ;

Claggett, Brian L. ;

Miao, Zi Michael ;

Kulac, Ian J. ;

Ward, Jonathan H. ;

Hernandez, Adrian F. ;

Morrow, David A. ;

Starling, Randall C. ;

Velazquez, Eric J. ;

Williamson, Kristin M. ;

Desai, Akshay S. ;

Zieroth, Shelley ;

Lefkowitz, Martin ;

McMurray, John J., V ;

Braunwald, Eugene ;

Solomon, Scott D. .

EUROPEAN HEART JOURNAL, 2023, 44 (31) :2982-2993

[10] Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US [J].

Vaduganathan, Muthiah ;

Claggett, Brian L. ;

Greene, Stephen J. ;

Aggarwal, Rahul ;

Bhatt, Ankeet S. ;

McMurray, John J. V. ;

Fonarow, Gregg C. ;

Solomon, Scott D. .

JAMA CARDIOLOGY, 2021, 6 (12) :1415-1423

← 1 2 →